Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: Long-term follow-up over more than 15 years

Clinical Research in Cardiology

Volumn 101, Issue 4, 2012, Pages 297-303

  Fischer, Dieter ^a   Gardiwal, Ajmal ^a   Haentjes, Jonas ^a   Klein, Gunnar ^a   Meyer, Gerd Peter ^a   Drexler, Helmut ^a   Hausmann, Dirk ^a   Schaefer, Arnd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Follow up; Paradoxical embolism; Patent foramen ovale; Prognosis; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHILD; COMPARATIVE STUDY; DISEASE ASSOCIATION; FATALITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LUNG CANCER; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; STROKE; SURVIVAL; TELECONSULTATION; THROMBOEMBOLISM; TRAFFIC ACCIDENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ADULT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; STROKE; THROMBOEMBOLISM; TIME FACTORS;

EID: 84860835751     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0392-2     Document Type: Article

References (25)

1. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S (1992) Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 117:461-465
2. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318:1148-1152
3. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G (1996) Stroke recurrence in patients with patent foramen ovale: the Lausanne study. Lausanne stroke with paradoxal embolism study group. Neurology 46:1301-1305 (Pubitemid 26159291)
4. Hanna JP, Sun JP, Furlan AJ, Stewart WJ, Sila CA, Tan M (1994) Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 25:782-786 (Pubitemid 24111323)
5. Hausmann D, Mugge A, Daniel WG (1995) Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 26:1030-1038
6. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP (1994) Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 25:582-586 (Pubitemid 24067070)
7. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guerin F, Bousser MG, de Recondo J (1993) Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24:1865-1873 (Pubitemid 23352717)
8. Stone DA, Godard J, Corretti MC, Kittner SJ, Sample C, Price TR, Plotnick GD (1996) Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 131:158-161 (Pubitemid 26021379)
9. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP (2002) Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 105:2625-2631 (Pubitemid 34596039)
10. Furlan AJ (2010) Closure I: a prospective, multicenter, randomized controlled trial to evaluate the safety and efficacy of the starflex® septal closure system versus best medical therapy in patients with a stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen oval. In: Abstract at the Annual Meeting of the American Heart Association 2010
11. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740-1746
12. Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R (2005) Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 101:77-82 (Pubitemid 40614739)
13. Feurer R, Sadikovic S, Sepp D, Esposito L, Schleef M, Bockelbrink A, Schwarze J, Hemmer B, Sander D, Poppert H (2010) Patent foramen ovale is not associated with an increased risk of stroke recurrence. Eur J Neurol 17(11):1339-1345
14. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD (2009) Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 73:89-97
15. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Denning K, Engberding R et al (1995) Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 91:2785-2792
16. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL (1988) Patent foramen ovale in young stroke patients. Lancet 2:11-12
17. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B (2004) Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 44:750-758 (Pubitemid 39099567)
18. Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N (2006) Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 68:741-746 (Pubitemid 44721098)
19. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, Brainin M, Homma S, Sacco RL (1998) Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29:944-948 (Pubitemid 28228154)
20. Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55:1172-1179
21. Balzer J, Kühl H, Rassaf T, Hoffmann R, Schauerte P, Kelm M, Franke A (2008) Real-time transesophageal three-dimensional echocardiography for guidance of percutaneous cardiac interventions: first experience. Clin Res Cardiol 97:565-574
22. Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M (2008) Figulla HR Clinical evaluation of a novel occluder device (Occlutech®) for percutaneous transcatheter closure of patent foramen ovale (PFO). Clin Res Cardiol 97:872-877
23. Fischer D, Haentjes J, Klein G, Schieffer B, Drexler H, Meyer GP, Schaefer A (2011) Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: Procedural and follow-up results after implantation of the Amplatzer®-occluder device. J Interv Cardiol 24:85-91
24. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH (2004) Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 25:424-430 (Pubitemid 38391525)
25. Laufs U, Hoppe UC, Rosenkranz S, Kirchhof P, Böhm M, Diener HC, Endres M, Grond M, Hacke W, Meinertz T, Ringelstein EB, Röther J, Dichgans M (2010) Cardiological evaluation after cerebral ischaemia: consensus statement of the Working Group Heart and Brain of the German Cardiac Society- Cardiovascular Research (DGK) and the German Stroke Society (DSG). Clin Res Cardiol 99:609-625